Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Other Accumulated Expenses (2022 - 2025)

Updated

Adaptin Bio (APTN) recorded Other Accumulated Expenses of $25,000 in Q4 2025, down 81.5% from $134,875 a year earlier.

Analysis

Adaptin Bio (APTN) Other Accumulated Expenses (2022 - 2025) Analysis & Trends

Starting with Q4 2022, Adaptin Bio's Other Accumulated Expenses history includes 8 quarters.

  • Annual Other Accumulated Expenses has a three-year compound annual growth rate of 18.6% (FY2022 to FY2025).
  • Across earlier years, Other Accumulated Expenses came in at $134,875 in FY2024 (+110.7%), $64,000 in FY2023 (+326.7%) and $15,000 in FY2022.
  • Quarterly Other Accumulated Expenses has ranged from $12,576 in Q1 2025 to $134,875 in Q4 2024 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Adaptin Bio 56.76 Mn 54.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 25,000.00
Mar 31, 2025 12,576.00
Dec 31, 2024 134,875.00
Sep 30, 2024 44,750.00
Jun 30, 2024 40,500.00
Mar 31, 2024 36,250.00
Dec 31, 2023 64,000.00
Dec 31, 2022 15,000.00
API Access

Adaptin Bio Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=APTN&period=max&api_key=YOUR_API_KEY